PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA 01605, USA.\', \'Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.\', \'Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China.\', \'Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, 300050, China.\', \'Bioinformatics Program, Boston University, Boston, MA 02215, USA.\', \'Corresponding author.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Discovery medicine
is ?:pmid of
?:pmid
?:pmid
  • 33007190
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.077
?:rankingScore_hIndex
  • 42
?:title
  • COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology.
?:type

Metadata

Anon_0  
expand all